Dr Meral Kayikcioglu
@MeralKayikcoglu
Prof of Cardiology, Director of Lipid & CV prevention clinic Ege University, EAS #SoMe Ambassador, Assoc Editor #ArchivesofTSC
ID:940611324916224000
12-12-2017 15:56:30
3,6K Tweets
7,7K Followers
2,7K Following
See the most current #knowledge on how to manage with #dyslipidemia in #pregnantwomen . It is an every-day #challange , and unfortunately most of our colleagues do not know how to proceed with severe dyslipidemia and #hypercholesterolemia in #pregnancy , increasing the risk of…
Monte-Carlo simulation analyzed inclisiran benefits in 500,000 individuals, showed a shift towards lower CV risk categories
🔗atherosclerosis-journal.com/article/S0021-…
Prof Kausik Ray FMedSci European Atherosclerosis Society #Inclisiran
Great science at the ACC session at #ESCPrev2024 with the dream team Erin D. Michos, M.D. Eugenia Gianos MD Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Prof Kausik Ray FMedSci SABOURETCardiologist Dr Meral Kayikcioglu
If you are interesting in being a European research site for the PROFID RCT then contact us:
[email protected]
The study is testing primary prevention ICD vs no ICD in post #heartattack patients with #heartfailure & LVEF ≤35% receiving OMT.
classic.clinicaltrials.gov/ct2/show/NCT05…
☝️Please stop talking about the “Lipid Hypothesis”
There is no such thing
👉It's an incorrect and outdated way to refer to the CAUSAL relationship between LDLc (ApoB) and Atherosclerosis (CHD)
European Atherosclerosis Society
#INOCA is not benign
🔹 MACE: 2% at 1y (CIAO ISCHEMIA), 1.32/100 person-year (MetaAnalysis 54 studies)
🔹Chest pain 🏥 : 4% at 1y (CIAO ISCHEMIA), 20% over 5y
Proper workup of INOCA to avoid MACE and high economic burder is necessary
#TCTAP2024
summitmd_cvrf
HFpEF | Optimising Therapy
🔹74% of 👥 are on > 10 💊‼️
🔹Many 👥 are on Rx that cause harm
🔸Perform regular medication reviews
🔸De-prescribe when possible
🔸Personalise their 💊
🔸Communicate the need for each Rx
#MedTwitter #CardioTwitter #ACC2024 American College of Cardiology
Such a wonderful #ESCPrev2024
Thank you for your hospitality and sharing the beautiful city of Athens with us.
Our love for #CVPrev is clearly a global movement that will be leading cardiology forward.
Now looking forward to #ESCPrev2025 in Milan!
It’s important to finish the job ‼️
🔑 Don’t forget to assess & manage residual risk in our ASCVD 👥
See below for risk factors & relevant clinical trials 👇🏼
#cardiotwitter #MedTwitter #ACC2024 American College of Cardiology #MedEd Erin D. Michos, M.D.
Very informative talk on lipid lowering in elderly by Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 at #ESCPrev2024 Prof Kausik Ray FMedSci SABOURETCardiologist Dr Meral Kayikcioglu
Congratulations, Lale Tokgozoglu 🎉👏 Her dedication to prevention is truly inspiring, and this award is so well-deserved.🧿🌷🩷 I am so proud to be mentored by such an incredible women! #wic #PreventionChampion #WellDeserved Turkish Society of Cardiology Maciej Banach EVANGELOS LIBEROPOULOS…
Prevention is better than cure! #ESCPrev2024 Prof. Dr. Barış Güngör Turkish Society of Cardiology Dr Meral Kayikcioglu
I am honored to receive the ESC Preventive Cardiology medal at #ESCPrev2024 Prof Kausik Ray FMedSci Borge G Nordestgaard Christoph Binder Turkish Society of Cardiology SABOURETCardiologist Eugenia Gianos MD Erin D. Michos, M.D. Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 Maciej Banach Dr Meral Kayikcioglu Barış Güngör Ozcan Basaran
Great overview of #Lpa by Erin D. Michos, M.D. reviewing risk, current treatments, what’s on the horizon & what the recent National Lipid Association statement she was a part of suggests. In line with #EAS recommendations- once in a lifestyle in all! #ESCPrev2024
FH management summarized nicely by Eugenia Gianos MD at #ESCPrev2024 Erin D. Michos, M.D. Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 SABOURETCardiologist Prof Kausik Ray FMedSci
